The Department of Health and Human Services’ Office for Civil Rights yesterday said it generally will not impose penalties for HIPAA rule violations on health care provider covered entities and their business associates operating COVID-19 community-based testing sites in good faith for the duration of the current national public health emergency. Community-based sites include mobile, drive-through or walk-up sites that provide only COVID-19 specimen collection or testing services to the public. OCR still encourages participating providers to implement reasonable safeguards to protect the privacy and security of individuals’ protected health information at the testing sites. The decision is retroactive to March 13.  

Related News Articles

Headline
The Food and Drug Administration yesterday released COVID-19 performance data for four more antibody test kits. The results come from the first collaboration…
Headline
The Department of Health and Human Services today released guidance specifying what data laboratories must report to HHS along with their COVID-19 test results…
Headline
The Food and Drug Administration this week released guidance for institutional review boards seeking clarity regarding the key factors and procedures they…
Headline
Social distancing interventions started earlier in the COVID-19 epidemic appear to delay the epidemic curve while interventions started later appear to flatten…
Headline
The Centers for Medicare & Medicaid Services recently issued new guidance implementing the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group,…
Headline
The Senate yesterday approved by unanimous consent the AHA-supported Paycheck Protection Program Flexibility Act of 2020 (H.R. 7010) to allow more leeway for…